The Effect of Everolimus Conjugated Albumin Nanocarrier on theViability of Lung Cancer A549 Cell Line
The findings confirm the synergistic anticancer effect of Eve@BSA, indicating that this nanosystem may serve as a promising candidate for the treatment of lung cancer.
Authors
- Fereshteh Chekin (ORCID: https://orcid.org/0000-0001-9477-248X)
- Ameneh Baghbani Rizi
- Bahman Rahimi Esboei
- Aroona Chabra
Institutions
- Islamic Azad University of Ayatollah Amoli (IR)
- Mazandaran University of Medical Sciences (IR)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2026-01-28
- DOI
- https://doi.org/10.2174/0109298673412510251024094728
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00